US cooperative group formed from CALGB, ACOSOG, and NCCTG; running OptimICE-pCR, which asks whether TNBC patients with a complete response still need a year of immunotherapy.
The Alliance for Clinical Trials in Oncology, based in Chicago, is the US cooperative group formed in 2011 from CALGB, ACOSOG and NCCTG, and a member of the NCI National Clinical Trials Network. Its trials include CALGB 40603, which tested carboplatin in triple-negative breast cancer, Z0011, which showed sentinel node biopsy could replace axillary dissection in selected patients, and A012103, the OptimICE-pCR trial asking whether TNBC patients with a pathologic complete response still need a year of pembrolizumab; ATOMIC and CABINET are also in OnCo, with Alan P. Venook and Evanthia Galanis among the people linked. OnCo connects it to bottlenecks on slow enrolment and the exclusion of older patients, and to ideas for a permanent surgical trials network. Whether de-escalation trials can recruit when the default is more treatment is its standing question. Its programmes are listed in the notes.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Alliance for Clinical Trials in Oncology, including child institutions. 42 works · 482 citations · 64% open access · 29% clinical trials · 2% reviews.
GI oncologist who led CALGB/SWOG 80405 and helped show that tumour side matters in colorectal cancer.
Evanthia Galanis is a brain tumour specialist who chairs one of the largest US clinical trial networks.
Shares ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials), Lung-MAP (SWOG S1400 and S1900), Older and multimorbid patients are excluded and undertreated, Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag cooperative-group.
Shares A statutory minimum share of public trial money for surgery and radiotherapy, ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials), Lung-MAP (SWOG S1400 and S1900), Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag cooperative-group.
Shares ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials), Lung-MAP (SWOG S1400 and S1900), Older and multimorbid patients are excluded and undertreated, Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag cooperative-group.
Shares Austrian Breast & Colorectal Cancer Study Group, ETOP IBCSG Partners Foundation, Triple-negative breast cancer (TNBC) and the tag cooperative-group.
Shares Austrian Breast & Colorectal Cancer Study Group, Carboplatin, Triple-negative breast cancer (TNBC) and the tag cooperative-group.
Shares A permanently funded international network for randomised cancer surgery trials, Trials enrol too few, too slowly, Resectable stage I to III non-small-cell lung cancer and the tag cooperative-group.
Shares Sentinel lymph node biopsy, National Cancer Institute (NIH), Colorectal cancer and the tag cooperative-group.
Shares ETOP IBCSG Partners Foundation, Triple-negative breast cancer (TNBC) and the tag cooperative-group.